[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Charles [@NotAnotherFlow](/creator/twitter/NotAnotherFlow) on x 2586 followers Created: 2025-07-13 21:13:44 UTC $APLS – Large $600K buyer of XXXXX $XX calls for 10/17 Not the best looking chart. Apellis is another biopharma company. Key Event - A supplemental NDA is under Priority Review with a July 28, 2025 PDUFA date. If approved, a U.S. launch is expected in the second half of 2025.  XXXXX engagements  **Related Topics** [approved](/topic/approved) [$600k](/topic/$600k) [$apls](/topic/$apls) [Post Link](https://x.com/NotAnotherFlow/status/1944505547103060182)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Charles @NotAnotherFlow on x 2586 followers
Created: 2025-07-13 21:13:44 UTC
$APLS – Large $600K buyer of XXXXX $XX calls for 10/17
Not the best looking chart. Apellis is another biopharma company.
Key Event - A supplemental NDA is under Priority Review with a July 28, 2025 PDUFA date. If approved, a U.S. launch is expected in the second half of 2025.
XXXXX engagements
/post/tweet::1944505547103060182